Effect of Addition and Subtraction Adjuvant Therapy of Bufeitang on Immune Inflammation After Tracheotomy in Stroke Patients with Syndrome of Deficiency of Spleen and Lung Qi

Xiao-shan LI; Xiao-hui ZHOU; Qian-qian FAN; Jing-jing PAN; Zhen-hua SONG

doi:10.13422/j.cnki.syfjx.20200633

您当前的位置：

首页 >

文章列表页 >

Effect of Addition and Subtraction Adjuvant Therapy of Bufeitang on Immune Inflammation After Tracheotomy in Stroke Patients with Syndrome of Deficiency of Spleen and Lung Qi

Clinic | 更新时间：2020-09-09

- Effect of Addition and Subtraction Adjuvant Therapy of Bufeitang on Immune Inflammation After Tracheotomy in Stroke Patients with Syndrome of Deficiency of Spleen and Lung Qi
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 26, Issue 18, Pages: 111-116(2020)
- 作者机构：
  
  1.中南大学湘雅医学院附属海口医院，海口 570208
  2.海南省中医院，海口 570208
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20200633
  CLC： R289;R25;R256;R256.1
- Received：02 March 2020，
  
  Published Online：10 April 2020，
  
  Published：20 September 2020
- 稿件说明：
移动端阅览
李小山,周晓晖,范倩倩等.补肺汤加减对脑卒中气管切开肺部感染脾肺气虚证患者免疫炎症的影响[J].中国实验方剂学杂志,2020,26(18):111-116.

LI Xiao-shan,ZHOU Xiao-hui,FAN Qian-qian,et al.Effect of Addition and Subtraction Adjuvant Therapy of Bufeitang on Immune Inflammation After Tracheotomy in Stroke Patients with Syndrome of Deficiency of Spleen and Lung Qi[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(18):111-116.
李小山,周晓晖,范倩倩等.补肺汤加减对脑卒中气管切开肺部感染脾肺气虚证患者免疫炎症的影响[J].中国实验方剂学杂志,2020,26(18):111-116. DOI： 10.13422/j.cnki.syfjx.20200633.

LI Xiao-shan,ZHOU Xiao-hui,FAN Qian-qian,et al.Effect of Addition and Subtraction Adjuvant Therapy of Bufeitang on Immune Inflammation After Tracheotomy in Stroke Patients with Syndrome of Deficiency of Spleen and Lung Qi[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(18):111-116. DOI： 10.13422/j.cnki.syfjx.20200633.

摘要

目的

探讨补肺汤加减辅助治疗脑卒中气管切开肺部感染（脾肺气虚证）的疗效及对免疫炎症的影响。

方法

将100例患者随机按数字表法分为对照组和观察组各50例。两组患者均给予注射用盐酸头孢吡肟，2 g/次，静脉滴注，每12 h 1次，并给予对症、支持等综合治疗。对照组经胃管给复方甘草口服溶液，10 mL/次，3次/d；观察组采用补肺汤加减，1剂/d，分早、晚2次经胃管给药。两组疗程均为连续治疗14 d。于治疗1 d，治疗7 d和治疗14 d进行临床肺部感染评分（CPIS），急性病生理和长期健康 Ⅱ（APACHE Ⅱ）评分；记录肺部感染控制时间和抗生素使用时间；检测治疗前后T淋巴细胞亚群（CD3

，CD4

，CD8

，CD4

/CD8

），调节性T细胞（Treg细胞）和免疫球蛋白[免疫球蛋白A（IgA），免疫球蛋白G(IgG)，血清免疫球蛋白M(IgM)水平；检测治疗前后降钙素原（PCT），肿瘤坏死因子-

（TNF-

），白细胞介素(IL)-1

，IL-6和IL-10水平；进行安全评价。

结果

观察组患者在治疗后7 d和14 d ，CPIS评分均低于对照组（

0.01）；观察组患者肺部感染控制时间和抗生素使用时间均短于对照组（

0.01）；观察组患者在治疗后7 d和14 d，APACHE Ⅱ评分均低于对照组（

0.01）；观察组患者Treg细胞，CD4

细胞和CD4

/CD8

均高于对照组（

0.05），CD8

细胞低于对照组（

0.05）；观察组患者IgA，IgM水平均较高于对照组（

0.01）；观察组患者PCT，TNF-

，IL-1

，IL-6和IL-10水平均低于对照组（

0.01）；研究期间未发现与补肺汤相关不良反应。

结论

在西医抗感染和对症支持等综合治疗的基础上，补肺汤加减能更有效控制脑卒中气管切开肺部感染的严重程度，减少咳嗽、咳痰，缩短了肺部感染的病程和抗生素的使用时间，并能调节免疫功能，抑制炎症反应。

Abstract

Objective

To discuss the efficacy of addition and subtraction adjuvant therapy of Bufei decoction for pulmonary infection after tracheotomy in stroke patients (syndrome of deficiency of spleen and lung Qi) and investigate its effect on immune inflammation.

Method

One hundred patients were randomly divided into control group (50 cases) and observation group (50 cases) by random number table. The patients in both groups got cefepime hydrochloride for injection

once every 12 hours

2 g/time， at the same time

symptomatic and supportive comprehensive treatment was given. Patients in control group additionally got compound glycyrrhiza oral solution via gastric tube

10 mL/time

3 times/day. Patients in observation group got addition and subtraction adjuvant therapy of Bufeitang every morning and night via gastric tube

1 dose/day. The treatment course was 14 days in both groups. At the 1

and 14

day after treatment

scores of clinical pulmonary infection scale (CPIS) and Acute Physiology and Chronic Health Evaluation Ⅱ (APACHE Ⅱ) were graded. The time to control pulmonary infection and the antibiotics use time were recorded. Before and after treatment

levels of T lymphocyte subsets (CD3

CD4

，CD8

and CD4

/CD8

)

regulatory T cells of (Treg cells)

immunoglobulin A (IgA)

immunoglobulin G (IgG)

immunoglobulin M(IgM)

procalcitonin (PCT)

tumor necrosis factor-

(TNF-

)

interleukin-1

IL-6 and IL-10 were detected

and safety was evaluated.

Result

At the 7

and 14

day after treatment

scores of CPIS and APACHE Ⅱ in observation group were lower than those in control group (

0.01). The time to control pulmonary infection and antibiotics use time were shorter than those in control group (

0.01). Levels of Treg cells

CD4

and CD4

/CD8

were higher than those in control group (

0.05). Levels of CD8

PCT

TNF-

IL-1

IL-6 and IL-10 were lower than that in control group (

0.01)

while levels of IgA and IgM were higher than those in control group (

0.01). There was no adverse reaction related to Bufeitang.

Conclusion

Based on comprehensive treatment of western medicine for anti-infection and symptomatic support

addition and subtraction adjuvant therapy of Bufeitang can effectively control the severity of pulmonary infection caused by tracheotomy in stroke

reduce coughing and expectoration

shorten the course of pulmonary infection and the use time of antibiotics

regulate immune function and inhibit inflammatory reaction.

关键词

Keywords

references

陈杏清 , 朱明月 , 邹玉婵 , 等 . 通元针法对卒中后气管切开患者拔管成功率的影响 [J]. 针刺研究 , 2019 , 44 ( 9 ): 663 - 667 .

WALCOTT B P ， KAMEL H ， CASTRO B ， et al . Tracheos-tomy after severe ischemic stroke：a population-based study [J]. J Stroke Cerebrovasc Dis , 2014 , 23 ( 5 ): 1024 - 1029 .

党帅 , 马进显 , 周国平 , 等 . 重症颅脑损伤气管切开患者肺部感染的治疗研究 [J]. 中华医院感染学杂志 , 2016 , 26 ( 1 ): 71 - 73 .

余果 , 王尔松 , 姚慧斌 . 重型颅脑损伤气管切开患者肺部感染的临床调查 [J]. 中华医院感染学杂志 , 2015 , 25 ( 14 ): 3263 - 3265 .

程耀南 , 邱玲 , 吴红瑛 . 健脾益气中药配合针刺对重型颅脑损伤气管切开术后患者肺部感染的干预作用 [J]. 长春中医药大学学报 , 2016 , 32 ( 2 ): 346 - 349 .

类家豪 , 林琳 . 中西医结合治疗重型颅脑损伤气管切开术后肺部感染患者的临床分析 [J]. 中医临床研究 , 2019 , 11 ( 7 ): 62 - 64 .

王珊珊 , 谭光波 . 补肺汤对慢性阻塞性肺疾病肺气肿大鼠血清IFN- γ ，IL-4表达水平影响研究 [J]. 陕西中医 , 2019 , 40 ( 11 ): 1491 - 1494 .

姚诗清 , 周兰 , 孙涛 , 等 . 补肺汤合参蛤散辨治联合伏九贴敷对稳定期COPD肺肾气虚证患者的防治 [J]. 中国实验方剂学杂志 , 2019 , 26 ( 7 ): 113 - 119 .

卫生部疾病控制司 , 中华医学会神经病学分会 . 中国脑血管病防治指南 [J]. 中国现代神经疾病杂志 , 2007 , 7 ( 2 ): 200 .

中华人民共和国卫生部 . 医院感染诊断标准(试行) [J]. 中华医学杂志 , 2001 , 81 ( 5 ): 61 - 67 .

中华中医药学会 . 中医内科常见病诊疗指南西医疾病部分 [M]. 北京 : 中国中医药科技出版社 , 2008 : 69 - 74 .

韩正贵 , 陆江涛 , 王文静 , 等 . 宣肺通腑汤辅助治疗中老年重症肺炎合并胃肠功能障碍的临床观察 [J]. 中国实验方剂学杂志 , 2018 , 24 ( 16 ): 188 - 193 .

李亚南 , 倪刚 , 葛晓忠 , 等 . 急性生理与慢性健康评分Ⅱ及血清肌钙蛋白Ⅰ对老年重症肺炎病情评估的临床意义 [J]. 安徽医学 , 2018 , 39 ( 12 ): 1505 - 1507 .

刘卫平 , 孙德俊 , 闫志刚 , 等 . 呼吸机相关性肺炎危险因素分析 [J]. 中华医院感染学杂志 , 2017 , 27 ( 1 ): 85 - 87 .

冯文涛 , 蔡文君 , 赵雷 , 等 . 中医药协助治疗呼吸机相关性肺炎的研究进展 [J]. 中国中医急症 , 2017 , 26 ( 10 ): 1793 - 1796 .

黄显雯 , 刘启华 , 邹玲 , 等 . 中风多虚多瘀多痰病机与自噬调控相关性的研究进展 [J]. 南京中医药大学学报 , 2020 , 36 ( 1 ): 130 - 135 .

曾凡军 , 王晓静 . 免疫功能监测在呼吸机相关肺炎患者预后评价中的作用 [J]. 临床肺科杂志 , 2015 , 20 ( 5 ): 838 - 840 .

周小青 , 李静 , 赵蕾 , 等 . 自然杀伤细胞通过树突状细胞调控衣原体肺部感染中Th17/Treg免疫应答平衡 [J]. 山东大学学报：医学版 , 2019 , 57 ( 4 ): 15 - 19 .

贵艳玲 , 蔡萍 , 程明琨 , 等 . ICU气管切开患者肺部感染病原菌对血清细胞因子影响的研究 [J]. 中华医院感染学杂志 , 2016 , 26 ( 11 ): 2494 - 2496 .

楼滟 , 王晓宇 , 张鹏 , 等 . 呼吸机相关性肺炎患者感染病原菌分布及炎症反应指标评价 [J]. 中华医院感染学杂志 , 2019 , 29 ( 7 ): 1003 - 1006 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Comparison of Relative Molecular Weight Distribution and Immune Activity of Polysaccharides in Polygonati Rhizoma Before and After Processing

Mechanisms of Traditional Chinese Medicine in Prevention and Treatment of Stroke by Regulating Ferroptosis： A Review

Yijingtang Reduces Ovarian Inflammatory Responses in Rat Model of Diminished Ovarian Reserve via TLR4/MyD88/NF-κB Signaling Pathway

Mechanism of Shengmai Injection Against Cerebral Ischemia Based on Proteomics

Pharmacodynamic Substances and Mechanisms of Da Chengqitang in Treating Stroke： A Review

Related Author

Xiao-ying WAN

Zhen-li LIU

Zhi-qian SONG

Zhang-chi NING

Shi-tao PENG

Dong-rui LIANG

Chun WANG

WEI Mingyan

Related Institution

Institute of Basic Theory of Chinese Medicine，China Academy of Chinese Medical Sciences

State Key Laboratory of Component-based Chinese Medicine， Tianjin University of Traditional Chinese Medicine

Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae，Ministry of Education，Tianjin University of Traditional Chinese Medicine

The First Clinical Medical School of Anhui University of Chinese Medicine

The First Affiliated Hospital of Anhui University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰